Integrated Development

As a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China, Fosun Pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Group Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.

  • Pharmaceutical Manufacturing

  • Vaccines

  • Medical Devices

  • Medical Diagnosis

  • Healthcare Services

  • Pharmaceutical Distribution and Retail

Steady Financial Growth

  • FY2021 Revenue

    39,005 million

    Increase of 28.70%

  • FY2021 Net Profit Attributable to shareholders

    4,735 million

    Increase of 29.28%

  • Net Profit Attributable to Shareholders of the Listed Company After the One-off Gain

    3,277 million

    Increase of 20.60%

* Unit: RMB million
As of 31 December 2021

Open R&D Ecology

  • In-house R&D
  • Co-Development
  • In-depth Incubation
  • License-in
  • Pharmaceutical Manufacturing

    Pharmaceutical Manufacturing

    In 2021, Fosun Pharma’s core business, the pharmaceutical manufacturing segment, achieved revenue of RMB28,904 million. We have a number of advantageous products in metabolism and digestive system, oncology and Immunomodulation, Anti-infection, cardiovascular system and other fields.

    • Oncology and Immunomodulation
    • Metabolism and Digestive System
    • Central Nervous System
    • Anti-infection
    • Cardiovascular System
    • APIs and Intermediates
  • Vaccines


    COMIRNATY® (mRNA COVID-19 vaccine) jointly developed by Fosun Pharma and BioNTech, was included in the government vaccination programs in Hong Kong SAR and Macau SAR in March 2021 and supplied to the Taiwan region in September 2021, helping to establish the local COVID-19 immune barrier.

    • COVID-19
    • mRNA COVID-19 Vaccine
  • Medical Devices

    Medical Devices

    As one of the important segments of Fosun Pharma, Fosun Med-tech integrated several subsidiaries at home and abroad and has initially formed three major business divisions with medical aesthetics, Respiratory Health and professional medical care

    • Medical Aesthetics
    • Respiratory Health
    • Professional Medical Technology and Devices
  • Medical Diagnosis

    Medical Diagnosis

    Founded in 1989, Fosun Diagnosis adheres to the mission of "Integrating innovative diagnostic technologies and protecting global life and health", promotes the development of innovative technologies and products, focuses on in vitro diagnosis industry, and is committed to becoming the world's leading technology innovator of integrated medical diagnosis solutions.

    • Biochemical Diagnosis
    • Immune Diagnosis
    • Molecular Diagnosis
    • Microbiological Diagnosis
    • Chronic-care Management
    • Pathological Diagnosis
  • Healthcare Services

    Healthcare Services

    Taking ‘‘making families healthier and life better’’ as the mission, Fosun Health gives full play to its core industrial advantages in the fields of medical care, medicine, insurance, health consumption, digital and intelligent technology, etc. Fosun Health is committed to building a medical-grade, full-scenario and one-stop health ecosystem, and becoming a ‘‘leader of active family health management’’.

    • Special Disease Healthcare
    • Consumer & Healthcare Services
    • Pharmaceutical
    • E-Commerce Insurance
    • Healthcare Services
  • Pharmaceutical Distribution and Retail

    Pharmaceutical Distribution and Retail

    In 2003, Fosun Pharma and China National Pharmaceutical Group Corporation jointly established Sinopharm Group.
    Sinopharm Group is a distributor of pharmaceuticals and healthcare products and a leading supply chain service provider in China.